Postnatal Genetic Tests’ Cost in Czechia, ProCrea Swiss IVF Center

Postnatal Genetic Tests’ Screening Bundles: Peripheral Blood Karyotyping, Cystic Fibrosis, Non–Syndromic Hearing Loss, Spinal Muscular Atrophy (SMA), Clinical Genetic Testing for Fragile X Syndrome (FSX), Detection of Y chromosome microdeletion in AZFa, AZFb, and AZFc loci, or all–in–one for all Postnatal Screening Bundle. * All–in–one for all Postnatal Screening Bundle (299 AR and X–linked genes) including Cystic Fibrosis, Non–Syndromic Hearing Loss Screening — autosomal recessive deafness 1A (DFNB1A), Spinal Muscular Atrophy diagnosis (SMA), and Carrier Screening from genome sequencing data (MLPA screening of exons 7, 8 of SMN1 and SMN2 Genes), and Clinical Genetic Testing for Fragile X Syndrome (FSX) by polymerase chain reaction amplification (PCR Screening of FMR1 CGG repeat expansion mutation detection).

Explore which pack is right for you. Starting at 125.00 EUR per testing.

ProCrea Swiss IVF Center:

1. ‘Where can I pre–order or book the PGS or PGD pack?’

Located in Prague, Czechia, ProCrea Swiss IVF Center has been successfully providing multiple options for IVF Treatment for 20+ years. ProCrea Swiss IVF Center specializes in performing Gynecology & Mammalogy, Urology & Andrology, Pregnancy Planning & Care, Procedures & Manipulations, Laboratory Tests & Genetic Analysis, Infertility Screening & Treatment, Surgical Treatment, MESA, PESA & TESA, Ovulation Induction (OI) cycles, IUI (Intrauterine Insemination) cycles, IVF, ICSI & PICSI cycles, Oocyte & Sperm Donation, Egg & Sperm Cryopreservation and Storage, Embryo Vitrification & Storage, Legal Support & Assistance. Explore all ‘core’ in–Bundle and out–Bundle configurations designed for IVF Programs.

Genetic counselling fees (pre–test and post–test):

Prenatal/Postnatal pre–test genetic counselling (appointment with Genetic Counselor) — 80.00 EUR.
Final Prenatal/Postnatal genetic post–test counselling with results (appointment with Genetic Counselor) — 70.00 EUR.
Prenatal/Postnatal pre–test genetic counselling (appointment with Genetic Counselor) plus Final Prenatal/Postnatal genetic post–test counselling with results’ interpretation Bundle’s cost is 150.00 EUR.

2. The available Postnatal Genetic Tests’ Bundles and their fees.

2.1. Peripheral Blood (PB) Karyotyping (Postnatal Genetic Test) ‘Core’ Bundle.

Pack #1: Peripheral Blood (PB) Karyotyping (chromosomal analysis) Postnatal Genetic Test: blood collection from a peripheral vein, the blood sample’s (samples’) prep. for Karyotyping (preliminary chromosome analysis intended to identify whole chromosome aneuploidies and large structural rearrangements and performed to confirm the diagnosis of a known aneuploid syndrome or detect a chromosome translocation), chromosomal investigation of Peripheral Blood (PB), and generation of the Personalized Profile with the valid test’s results

Bundle’s cost starts at 197.00 EUR per test.

‘What is in the Bundle?’

The Peripheral Blood Karyotyping Protocol’s preconfiguration by the Genetic Counselor with its further discussion and empowerment.

Blood collection from a peripheral vein.

The blood sample’s (samples’) prep. for Karyotyping (preliminary chromosome analysis intended to Identify whole chromosome aneuploidies and large structural rearrangements and performed to confirm the diagnosis of a known aneuploid syndrome or detect a chromosome translocation).

Chromosomal investigation of peripheral blood (PB) including detection of:

Microscopically visible chromosome rearrangements (>5–10Mb);
Balanced chromosome rearrangements such as translocations, inversions;
Suspected sex chromosome aneuploidy such as Turner syndrome Klinefelter syndrome, Triple X;
Strongly suspected aneuploidy, such as Trisomy 21;
Confirmation of abnormal rapid FISH screen.

Generation of the Personalized Profile with the valid test’s results.

2.2. Cystic Fibrosis (Postnatal (newborn’s) Screening) ‘Core’ Bundle.

Pack #2: Cystic Fibrosis (Postnatal Screening): blood collection from a vein, the blood sample’s (samples’) prep. for Cystic Fibrosis screening (screening for 33 CFTR gene mutations through Devyser Core kit), Cystic Fibrosis screening with targeted detection of the gene mutations, and generation of the Personalized Profile with the valid test’s results

Bundle’s cost starts at 270.00 EUR per screening.

‘What is in the Bundle?’

The Cystic Fibrosis Screening Protocol’s preconfiguration by the Genetic Counselor with its further discussion and empowerment.
Blood collection from a vein.
the blood sample’s (samples’) prep. for Cystic Fibrosis screening (screening for 33 CFTR gene mutations through Devyser Core kit).
Cystic Fibrosis screening powered up by using the Devyser Core kit (the Genetic Counselor will power up the CFTR — Allele–Specific Devyser Core kit (offers a complete set of diagnostic kits for detection of CFTR mutations by allele–specific analysis, and detects the 33–36 most common mutations, polythymidine variants (5T/7T/9T) within intron 9 (IVS8) of the CFTR, in case of a 5T variant, also detects the TG repeat number.
Generation of the Personalized Profile with the valid test’s results.

‘What is not in the Bundle?’

Cystic Fibrosis screening powered up by using the Devyser CFTR 68 kit (detects 68 mutations, polyT tract and the associated number of TG repeats, only 2 mixes: one wild–type mix and one mutation mix including the wild–type allele for the F508 deletion to check its zygosity, and detects sample mix–up using cross–mix ID) Bundle’s cost is available on–demand.
Cystic Fibrosis screening powered up by using the Devyser Allele–specific detection of common CFTR mutations kit for allele specific detection of CFTR mutations rely on multiplex allele–specific PCR amplification for detection of normal non–mutated, and mutated alleles in the CFTR gene Bundle’s cost is available on–demand.

2.3. Non–Syndromic Hearing Loss (Postnatal Screening) ‘Core’ Bundle.

Pack #3: Newborn hearing screening program ‘Non–Syndromic Hearing Loss screening for hearing loss disorder — Autosomal recessive deafness 1A (DFNB1A)’: prep. for non–syndromic hearing loss screening, clinical test for Deafness that detects the presence of 35delG, W24X in GJB2 gene for transmembrane protein connexin 26 (Cx26)), and generation of the Personalized Profile with the valid test’s results

Bundle’s cost starts at 115.00 EUR per testing.

‘What is in the Bundle?’

The Non–Syndromic Hearing Loss — Autosomal recessive deafness 1A (DFNB1A) Screening Protocol’s preconfiguration by the Genetic Counselor with its further discussion and empowerment.
Prep. for non–syndromic hearing loss screening.
Clinical test for Deafness that detects the presence of 35delG, W24X in GJB2 gene for transmembrane protein connexin 26 (Cx26)).
Generation of the Personalized Profile with the valid test’s results.

Pack #4: Newborn hearing screening program ‘Non–Syndromic Hearing Loss screening for hearing loss disorder — Autosomal recessive deafness 1A (DFNB1A), direct sequencing of GJB2 gene for transmembrane protein connexin 26 (Cx26)’: prep. for non–syndromic hearing loss screening, clinical test for Deafness (direct sequencing of GJB2 gene for transmembrane protein connexin 26 (Cx26)), and generation of the Personalized Profile with the valid test’s results

Bundle’s cost starts at 115.00 EUR per testing.

‘What is in the Bundle?’

The Non–Syndromic Hearing Loss — Autosomal recessive deafness 1A (DFNB1A), direct sequencing of GJB2 gene for transmembrane protein connexin 26 (Cx26) Screening Protocol’s preconfiguration by the Genetic Counselor with its further discussion and empowerment.
prep. for non–syndromic hearing loss screening.
clinical test for Deafness (direct sequencing of GJB2 gene for transmembrane protein connexin 26 (Cx26)).
generation of the Personalized Profile with the valid test’s results.

2.4. Spinal Muscular Atrophy diagnosis (SMA — an autosomal recessive neuromuscular disorder, caused by loss of the SMN1 and SMN2 genes), and carrier screening from genome sequencing data (MLPA screening of exons 7, 8 of SMN1 and SMN2 Genes) Postnatal Screening ‘Core’ Bundle.

Pack #5: Spinal Muscular Atrophy Diagnosis (SMA — an autosomal recessive neuromuscular disorder, caused by loss of the SMN1 and SMN2 genes), and carrier screening from genome sequencing data (MLPA screening of exons 7, 8 of SMN1 and SMN2 Genes): prep. for Spinal Muscular Atrophy Screening, Spinal Muscular Atrophy Screening (MLPA Screening of exons 7, 8 of SMN1 and SMN2 Genes), and generation of the Personalized Profile with the valid test’s results

Bundle’s cost starts at 125.00 EUR per testing.

‘What is in the Bundle?’

The Spinal Muscular Atrophy (SMA) Screening Protocol’s preconfiguration by the Genetic Counselor with its further discussion and empowerment.
Prep. for Spinal Muscular Atrophy (SMA) screening.
Spinal Muscular Atrophy Screening (MLPA Screening of exons 7, 8 of SMN1 and SMN2 Genes).
Generation of the Personalized Profile with the valid test’s results.

2.5. Clinical Genetic Testing for Fragile X Syndrome (FSX) by Polymerase Chain Reaction Amplification (PCR Screening of FMR1 CGG repeat expansion mutation detection) Postnatal Screening ‘Core’ Bundle.

Pack #6: Clinical Genetic Testing for Fragile X Syndrome (FSX) by Polymerase Chain Reaction Amplification (PCR screening of FMR1 CGG repeat expansion mutation detection): prep. for clinical Genetic Testing for Fragile X Syndrome (FSX), clinical Genetic Testing for Fragile X Syndrome (FSX) by polymerase chain reaction amplification (PCR Screening of FMR1 CGG repeat expansion mutation detection) — quantifying Cytosine–Guanine–Guanine (CGG) repeat expansion mutation, and generation of the Personalized Profile with the valid test’s results

Bundle’s cost starts at 240.00 EUR per clinical Genetic Testing.

‘What is in the Bundle?’

The clinical Genetic Testing for Fragile X Syndrome (FSX) by polymerase chain reaction amplification (PCR Screening of FMR1 CGG repeat expansion mutation detection) Screening Protocol’s preconfiguration by the Genetic Counselor with its further discussion and empowerment.
Prep. for clinical Genetic Testing for Fragile X Syndrome (FSX) screening.
Clinical Genetic Testing for Fragile X Syndrome (FSX) by polymerase chain reaction amplification (PCR Screening of FMR1 CGG repeat expansion mutation detection) — quantifying Cytosine–guanine–guanine (CGG) repeat expansion mutation.
Generation of the Personalized Profile with the valid test’s results.

2.6. Detection of Y chromosome microdeletion in AZFa, AZFb, and AZFc loci using sequence–tagged sites (STSs) (Postnatal Screening) ‘Core’ Bundle.

Pack #7: Detection of Y chromosome microdeletion in AZFa, AZFb, and AZFc loci using sequence–tagged sites (STSs): prep. for clinical testing, Detection of Y chromosome microdeletion in AZFa, AZFb, and AZFc loci using sequence–tagged sites (STSs) through performing polymerase chain reaction (PCR) on the loci spanning the AZFa, AZFb, and AZFc subregions of the Y chromosome, and generation of the Personalized Profile with the valid test’s results

Bundle’s cost starts at 175.00 EUR per clinical Genetic Testing.

‘What is in the Bundle?’

Detection of Y chromosome microdeletion in AZFa, AZFb, and AZFc loci using sequence–tagged sites (STSs) Screening Protocol’s preconfiguration by the Genetic Counselor with its further discussion and empowerment.
prep. for Genetic Testing.
detection of Y chromosome microdeletion in AZFa, AZFb, and AZFc loci using sequence–tagged sites (STSs) through performing Polymerase Chain Reaction (PCR) on the loci spanning the AZFa, AZFb, and AZFc subregions of the Y chromosome.
generation of the Personalized Profile with the valid test’s results.

2.7. All–in–one for all Postnatal Screening Bundle (299 AR and X–linked genes) including Cystic Fibrosis, Non–Syndromic Hearing Loss screening — autosomal recessive deafness 1A (DFNB1A), Spinal Muscular Atrophy Diagnosis (SMA), and carrier screening from genome sequencing data (MLPA screening of exons 7, 8 of SMN1 and SMN2 Genes), and Clinical Genetic Testing for Fragile X Syndrome (FSX) by polymerase chain reaction amplification (PCR screening of FMR1 CGG repeat expansion mutation detection).

Pack #8: All–in–one for all Postnatal Screening Bundle (299 AR and X–linked genes) including Cystic Fibrosis, Non–Syndromic Hearing Loss screening — autosomal recessive deafness 1A (DFNB1A), Spinal Muscular Atrophy diagnosis (SMA), and carrier screening from genome sequencing data (MLPA screening of exons 7, 8 of SMN1 and SMN2 Genes), and Clinical Genetic Testing for Fragile X Syndrome (FSX) by polymerase chain reaction amplification (PCR screening of FMR1 CGG repeat expansion mutation detection): prep. for testing, testing, and generation of the Personalized Profile with the valid test’s results

Bundle’s cost starts at 600.00 EUR per clinical Genetic Testing.

‘What is in the Bundle?’

299 AR and X–linked genes including Cystic Fibrosis, Non–Syndromic Hearing Loss screening — autosomal recessive deafness 1A (DFNB1A), Spinal Muscular Atrophy diagnosis (SMA), and carrier screening from genome sequencing data (MLPA screening of exons 7, 8 of SMN1 and SMN2 Genes), and Clinical Genetic Testing for Fragile X Syndrome (FSX) by polymerase chain reaction amplification (PCR screening of FMR1 CGG repeat expansion mutation detection) Screening Protocol’s preconfiguration by the Genetic Counselor with its further discussion and empowerment.
Prep. for testing.
Performing testing according to the screening Protocol.
Generation of the Personalized Profile with the valid test’s results.

Something to say in conclusion?

Need help finding the perfect IVF Bundle? Chat with a Specialist and Get a Free Quote from ProCrea Swiss IVF Center.